Evidence map›Paper›PMID 40379261›Full record

ArticleBrain : a journal of neurology2025

FGF14 repeat length and mosaic interruptions: modifiers of spinocerebellar ataxia 27B?

Joshua Laß, Mirja Thomsen, Max Borsche, Theresa Lüth, Julia C Prietzsche, Susen Schaake, Andona Milovanović, Hannah Macpherson, Emil K Gustavsson, Paula Saffie Awad and 8 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Clinical, Genetic, and Imaging Characteristics of SCA27B: Insights from a Large Dutch Cohort.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Joshua LaßInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.
Mirja ThomsenInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.ORCID 0009-0004-1148-5493
Max BorscheInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.
Theresa LüthInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.
Julia C PrietzscheInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.
Susen SchaakeInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.
Andona MilovanovićNeurology Clinic, University Clinical Center of Serbia, Belgrade 11000, Serbia.
Hannah MacphersonDepartment of Genetics and Genomic Medicine, UCL GOS Institute of Child Health, London WC1E 6BT, UK.
Emil K GustavssonDepartment of Genetics and Genomic Medicine, UCL GOS Institute of Child Health, London WC1E 6BT, UK.ORCID 0000-0003-0541-7537
Paula Saffie AwadPrograma de Pós-Graduação em Ciências Médicas, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035003, Brazil.
Nataša Dragašević-MiškovićNeurology Clinic, University Clinical Center of Serbia, Belgrade 11000, Serbia.
Björn-Hergen LaabsInstitute of Medical Biometry and Statistics, University of Lübeck, Lübeck 23538, Germany.
Inke R KönigInstitute of Medical Biometry and Statistics, University of Lübeck, Lübeck 23538, Germany.
Ana WestenbergerInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.ORCID 0000-0001-8062-6959
Christopher E PearsonDepartment of Molecular Genetics, The Hospital for Sick Children, Genetics & Genome Biology, University of Toronto, Toronto, ON M5G 0A4, Canada.ORCID 0000-0001-9545-4205
Norbert BrüggemannInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.
Christine KleinInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.
Joanne TrinhInstitute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck 23538, Germany.

Funding

CIHR FRN-148910CIHR FRN-173282German Research Foundation BR4328.2-1German Research Foundation FOR2488German Research Foundation GRK1957
6 · The paper itself

Abstract

Deep intronic FGF14 repeat expansions have been identified as a frequent genetic cause of late-onset cerebellar ataxias, explaining ≤30% of patients. Interruptions between repeats have previously been identified to impact the penetrance in other repeat expansion disorders. Repeat interruptions within FGF14 have yet to be characterized in detail. We used long-range PCR, Sanger sequencing, repeat-primed PCR, Nanopore and PacBio sequencing to distinguish the repeat motifs, mosaicism and number of repeat interruptions present in FGF14-related ataxia patients and unaffected individuals. A total of 304 patients with late-onset ataxia and 190 unaffected individuals were previously screened for repeat expansions in FGF14 by long-range PCR, identifying 37 individuals with expanded repeat lengths (≥250 repeats). These, along with three newly identified expansion carriers were included in the present study, and advanced genetic methods were applied to investigate the repeat composition in 27 patients and 13 unaffected individuals. The expansions, based on Nanopore data, ranged from 236 to 486 repeats (standard deviation = 60), with 20 individuals showing repeat interruptions, including complex motifs such as GAG, GAAGGA, GAAGAAAGAA, GAAAAGAAGAAGGAAGAAGGAA, GAAAAGAAGAAGGAA and GCAGAAGAAGAAGAA. We calculated the longest pure GAA length from the long-read data for all 40 individuals. When comparing the pure GAA tract between patients and unaffected individuals, clusters were apparent based on >200 or <200 repeats. Five ataxia patients with interruptions still had a remaining pure GAA expansion <200. We observed an association of the pure GAA length with age at onset (P = 0.016, R2 = 0.256). Somatically incurred mosaic divergent repeat interruptions were discovered that affect motif length and sequence (mDRILS), which varied in number and mosaicism (frequency: 0.37-0.93). The mDRILS were correlated with pure GAA length (P = 0.022, R2 = 0.334), with a higher mosaic frequency of interruptions in unaffected individuals compared with patients (unaffected: 0.90; patients: 0.67; P = 0.009). We demonstrate that: (i) long-read sequencing is required to detect complex repeat interruptions accurately; (ii) repeat interruptions in FGF14 are mosaic, have various lengths and start positions in the repeat tract, and can thereby be annotated as mDRILS; which (iii) enabled us to establish a categorization based on remaining pure GAA repeats quantifying the impact of mDRILS on pathogenicity or age at onset, dependent on the interruption length and position, with high accuracy; and (iv) we provide evidence that mosaicism stabilizes pure GAA repeats in interrupted FGF14 repeat expansions.

Indexed as

DNA Repeat ExpansionFibroblast Growth FactorsMosaicismSpinocerebellar AtaxiasAdultAgedFemaleHumansMaleMiddle Agedfibroblast growth factor 14Fibroblast Growth Factorsinterruptionslong-read sequencingrepeat expansionSCA27B

Identifiers

PMID40379261
PMCPMC12588676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.